Skip to main content

Table 1 Potential biomarkers of metabolites for filtering significantly changed by C. longa extract and demethoxycurcumin 60 µM treatment (AUC ≥ 0.7)

From: Metabolomics reveals that Curcuma longa and demethoxycurcumin inhibit HCT116 human colon cancer cell growth

CON → CL

CON → DMC60

Metabolites

AUC

Concentration changes

Metabolites

AUC

Concentration changes

Alanine***

1.00

AMP***

1.00

Arginine***

1.00

Formate***

1.00

Aspartate***

1.00

Glycine***

1.00

Betaine***

1.00

Lactate***

1.00

Creatine***

1.00

NAD + ***

1.00

Glutamate***

1.00

Succinate***

1.00

GSH***

1.00

UDP-NAG***

1.00

Glycine***

1.00

UMP***

1.00

Lactate***

1.00

Uracil***

1.00

Phenylalanine***

1.00

Uridine***

1.00

Threonine***

1.00

mI***

1.00

Uracil***

1.00

GPC***

1.00

Valine***

1.00

Aspartate***

0.99

Methionine***

0.99

Valine***

0.97

Serine***

0.99

ADP***

0.94

Taurine***

0.99

4HP**

0.94

DMA**

0.95

DMA**

0.91

Isoleucine***

0.95

Inosine***

0.91

Leucine***

0.95

Glycerol**

0.90

Histidine**

0.92

Tyrosine***

0.90

Tyrosine***

0.92

NAA**

0.89

Uridine***

0.85

ATP**

0.86

Succinate**

0.83

Acetate**

0.84

mI*

0.82

Leucine*

0.83

NAA*

0.81

Betaine

0.83

GPC*

0.80

Threonine*

0.80

NAD + *

0.78

Choline*

0.77

Formate*

0.73

Glucose

0.77

ATP

0.70

Histidine*

0.76

   

Isoleucine

0.73

   

Glutamate

0.71

   

PC*

0.71

  1. *, statistically different from control group with p < 0.05; **, statistically different from CON with p < 0.01; ***, statistically different from CON with p < 0.001. DMA dimethylamine, mI myo-inositol, 4-HP trans-4-hydroxy-L-proline, GSH glutathione, PC O-phosphocholine, NAA N-acetylaspartate, GPC sn-glycerol-3-phosphocholine, UDP-NAG UDP-N-acetylglucosamine